Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

The priming of an immune response against a major histocompatibility complex class I-restricted antigen expressed by nonhematopoietic cells involves the transfer of that antigen to a host bone marrow-derived antigen presenting cell (APC) for presentation to CD8+ T lymphocytes. Dendritic cells (DC), as bone marrow-derived APC, are first candidates for presentation of tumor-associated antigens (TAA). The aim of this study was to see whether DC are able to prime in vivo antigen-specific cytotoxic T lymphocytes after exposure to a soluble protein antigen in vitro. Lacking a well-defined murine TAA, we took advantage of beta- galactosidase (beta-gal)-transduced tumor cell lines as a model in which beta-gal operationally functions as TAA. For in vivo priming both a DC line, transduced or not transduced with the gene coding for murine GM-CSF, and fresh bone marrow-derived DC (bm-DC), loaded in vitro with soluble beta-gal, were used. Priming with either granulocyte macrophage colony-stimulating factor-transduced DC line or fresh bm-DC but not with untransduced DC line generated CTL able to lyse beta-gal- transfected target cells. Furthermore, GM-CSF was necessary for the DC line to efficiently present soluble beta-gal as an H-2Ld-restricted peptide to a beta-gal-specific CTL clone. Data also show that a long- lasting immunity against tumor challenge can be induced using beta-gal- pulsed bm-DC as vaccine. These results indicate that effector cells can be recruited and activated in vivo by antigen-pulsed DC, providing an efficient immune reaction against tumors.

• Publication year

  1996

• Venue

  Journal of Experimental Medicine

• Publication date

  1996-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1084/JEM.183.1.317PMID 8551239PMCID 2192419
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood.

  1995cited by this paper
• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

  1994cited by this paper
• Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.

  1994cited by this paper
• Immune response against tumors.

  1994influential reference
• Murine epidermal Langerhans cells and splenic dendritic cells present tumor‐associated antigens to primed T cells

  1994cited by this paper
• Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo

  1994cited by this paper
• Tumor antigens recognized by T lymphocytes.

  1994cited by this paper
• Tumour antigens. A new look for the 1990s.

  1994cited by this paper
• Retroviral Vector-Mediated Gene Transfer into Human Primary Myogenic Cells Leads to Expression in Muscle Fibers In Vivo

  1993cited by this paper
• The biochemistry and cell biology of antigen processing and presentation.

  1993cited by this paper
• The role of dendritic cells in the regulation of T cell cytokine synthesis.

  1993cited by this paper
• Immortalized dendritic cell line fully competent in antigen presentation initiates primary T cell responses in vivo

  1993influential reference
• Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes.

  1993cited by this paper
• Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo

  1993cited by this paper
• Role of dendritic cells in the priming of CD4+ T lymphocytes to peptide antigen in vivo.

  1993cited by this paper
• Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

  1992cited by this paper
• Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes

  1992cited by this paper
• Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo

  1991cited by this paper
• Tumor antigen presentation by murine epidermal cells.

  1991cited by this paper
• The dendritic cell system and its role in immunogenicity.

  1991cited by this paper
• Dendritic cells pulsed with protein antigens in vitro can prime antigen- specific, MHC-restricted T cells in situ [published erratum appears in J Exp Med 1990 Oct 1;172(4):1275]

  1990cited by this paper
• Class I-restricted processing and presentation of exogenous cell- associated antigen in vivo

  1990cited by this paper
• Protein-specific cytotoxic T lymphocytes. Recognition of transfectants expressing intracellular, membrane-associated or secreted forms of beta-galactosidase.

  1989cited by this paper
• Improved retroviral vectors for gene transfer and expression.

  1989cited by this paper
• Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro

  1989cited by this paper
• Construction and use of a safe and efficient amphotropic packaging cell line.

  1988cited by this paper
• Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells

  1987cited by this paper
• Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay

  1976cited by this paper

• Starting the Engine and Releasing the Brakes of T-Cell Responses: A Biomimetic Dendritic Cell Nanoplatform for Improved Glioblastoma Immunotherapy.

  2025cites this paper
• Effect of Enzymatic Glycosylation on Film-Processing Properties and Biological Activities of Black Soybean Protein

  2025cites this paper
• Proteomimetic Polymers Trigger Potent Antigen-Specific T Cell Responses to Limit Tumor Growth.

  2024cites this paper
• Pathways of MHC I cross-presentation of exogenous antigens.

  2023cites this paper
• Dendritic cell transfer for cancer immunotherapy.

  2022cites this paper
• Trial watch: Dendritic cell (DC)-based immunotherapy for cancer

  2022cites this paper
• Bacteria-Based Immune Therapies for Cancer Treatment.

  2021cites this paper
• Photoacoustic-immune therapy with a multi-purpose black phosphorus-based nanoparticle

  2020cites this paper
• Full Proceeding Paper IN LABORATORY GENERATION AND MATURATION OF HUMAN MONOCYTE-DERIVED DENDRITIC CELLS FOR CANCER IMMUNOTHERAPY

  2020cites this paper
• Recent Advances in Nanotechnology for Dendritic Cell-Based Immunotherapy

  2020cites this paper
• Cell death induced by cytotoxic CD8+ T cells is immunogenic and primes caspase-3–dependent spread immunity against endogenous tumor antigens

  2020cites this paper
• Autologous dendritic cells pulsed with lysate from an allogeneic hepatic cancer cell line as a treatment for patients with advanced hepatocellular carcinoma: A pilot study.

  2020cites this paper
• LILRA3 is related to monocyte-derived dendritic cell maturation and activation

  2020cites this paper
• Overexpression of microRNA-155 enhances the efficacy of dendritic cell vaccine against breast cancer

  2020cites this paper
• Trial watch: dendritic cell vaccination for cancer immunotherapy

  2019cites this paper
• CD11c+ MHCIIlo GM-CSF-bone marrow-derived dendritic cells act as antigen donor cells and as antigen presenting cells in neoepitope-elicited tumor immunity against a mouse fibrosarcoma

  2018cites this paper
• 3-Day monocyte-derived dendritic cells stimulated with a combination of OK432, TLR7/8 ligand, and prostaglandin E2 are a promising alternative for cancer immunotherapy

  2018cites this paper
• Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents

  2018cites this paper
• Therapeutic Potential of Bacteria against Solid Tumors.

  2017cites this paper
• VISUALIZING THE DYNAMICS OF IMMUNE SURVEILLANCE IN BRAIN TUMORS BY INTRAVITAL MULTIPHOTON MICROSCOPY

  2017cites this paper
• Vaccination with DC/tumor fusion cells results in cellular and humoral anti-tumor immune responses in patients with multiple myeloma DC/myeloma fusion vaccine induces immune responses

  2017cites this paper
• COMPOSITION COMPRISING AN ADENOVIRAL, EXPRESSION VECTOR COMPRISINGA CD4OL FUSION PROTEIN FOR GENERATING IMMUNE RESPONSES

  2017cites this paper
• Trial watch: Dendritic cell-based anticancer immunotherapy

  2017cites this paper
• Oncogenic miR-155 down-regulated upon activation of antitumor cytotoxic T lymphocytes by the fusion of dendritic cells with breast carcinoma cells.

  2017cites this paper
• Dendritic Cell Maturation is a Critical Step in Dendritic Cell Vaccine Preparation for Cancer Therapy

  2016cites this paper
• Efficient generation of antigen-specific CTLs by the BAFF-activated human B Lymphocytes as APCs: a novel approach for immunotherapy

  2016cites this paper
• Induction of CD4+ and CD8+ anti‐tumor effector T cell responses by bacteria mediated tumor therapy

  2015cites this paper
• Spatial separation of the processing and MHC class I loading compartments for cross-presentation of the tumor-associated antigen HER2/neu by human dendritic cells

  2015cites this paper
• Comparative analysis of cytotoxic T lymphocyte response induced by dendritic cells pulsed with recombinant adeno-associated virus carrying α-fetoprotein gene or cancer cell lysate.

  2015cites this paper
• Dendritic cell immunotherapy for brain tumors

  2015cites this paper
• Advances in strategies and methodologies in cancer immunotherapy.

  2015cites this paper
• Cancer therapeutic potential of combinatorial immuno- and vasomodulatory interventions

  2015cites this paper
• Antigen-loaded dendritic cell migration: MR imaging in a pancreatic carcinoma model.

  2015cites this paper
• Cancer vaccines

  2015cites this paper
• Dendritic Cell Vaccine and its Application in Cancer Therapy

  2015cites this paper
• Uric acid enhances the antitumor immunity of dendritic cell-based vaccine

  2015cites this paper
• Programmed nanoparticles for combined immunomodulation, antigen presentation and tracking of immunotherapeutic cells.

  2014cites this paper
• The nanomaterial-dependent modulation of dendritic cells and its potential influence on therapeutic immunosuppression in lupus.

  2014cites this paper
• Dendritic cells and hepatocellular carcinoma.

  2014cites this paper
• Antitumor effect of dendritic cell loaded ex vivo and in vivo with tumor-associated antigens in lung cancer model

  2014cites this paper
• Dendritic cell vaccines against non-small cell lung cancer -  an emerging therapeutic alternative.

  2014cites this paper
• Dendritic cells and hepatocellular carcinoma

  2014cites this paper
• Trial watch: Dendritic cell-based anticancer therapy

  2014cites this paper
• Augmentation of Antitumor Immunity by Fusions of Ethanol-Treated Tumor Cells and Dendritic Cells Stimulated via Dual TLRs through TGF-β1 Blockade and IL-12p70 Production

  2013cites this paper
• TAPCells, the Chilean dendritic cell vaccine against melanoma and prostate cancer.

  2013cites this paper
• Trial watch

  2013cites this paper
• Etude de l’efficacité et des mécanismes de la présentation croisée d’antigènes cellulaires tumoraux intacts par les cellules dendritiques

  2013cites this paper
• antigen-presenting cells: potential for clinical application efficiently induced by means of CD40-activated B cells as Human primary and memory cytotoxic T lymphocyte responses are

  2013cites this paper
• Untreated Stage IV Melanoma Patients Exhibit Abnormal Monocyte Phenotypes and Decreased Functional Capacity

  2013cites this paper
• Current Status and Future Perspectives of Dendritic Cell–Based Cancer Immunotherapy

  2013cites this paper
• T lymphocyte responses effective in vitro vaccine designed to elicit EBV-specific CD4+ and CD8+ thaw cell lysates define an - Mature dendritic cells pulsed with freeze

  2013cites this paper
• Characterization of structure and direct antigen presentation by dendritic/tumor-fused cells as cancer vaccines.

  2013cites this paper
• RNA pulsed dendritic cells: an approach for cancer immunotherapy.

  2013cites this paper
• Fusions between dendritic cells and whole tumor cells as anticancer vaccines

  2013cites this paper
• Trial watch

  2012cites this paper
• Dendritic/tumor fusion cells as cancer vaccines.

  2012cites this paper
• In vitro analysis of T cell responses induced by breast tumor cell lysate pulsed with autologous dendritic cells

  2012cites this paper
• Immunotherapy of High-Grade Gliomas: Preclinical In Vivo Experiments in Animal Models

  2012cites this paper
• Dendritic Cell (DC) Vaccine in Mouse Lung Cancer Minimal Residual Model; Comparison of Monocyte-derived DC vs. Hematopoietic Stem Cell Derived-DC

  2012cites this paper
• Dendritic cell-based vaccines: barriers and opportunities.

  2012cites this paper
• Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies

  2011cites this paper
• Simultaneous in vivo tracking of dendritic cells and priming of an antigen-specific immune response.

  2011cites this paper
• Cancer vaccines in phase II/III clinical trials: state of the art and future perspectives.

  2011cites this paper
• THE EFFECTS OF T-CELL CONDITIONED MEDIA ON THE INDUCTION OF DENDRITIC CELL (DC1) MATURATION FOR EFFECTIVE TUMOR IMMUNOTHERAPY

  2011cites this paper
• Dendritic Cells Crosspresent Antigens from Live B16 Cells More Efficiently than from Apoptotic Cells and Protect from Melanoma in a Therapeutic Model

  2011cites this paper
• Association entre les dérégulations des cellules dendritiques et les altérations des lymphocytes B présentes chez les patients infectés par le VIH

  2011cites this paper
• Cell Fusion and Dendritic Cell-Based Vaccines

  2011cites this paper
• Role of NK cells in DC-based immunotherapy of melanoma

  2011cites this paper
• Development of tools to target antigen through mannose receptor

  2011cites this paper
• Isolierung und Charakterisierung tumorassoziierter MHC- Klasse-I- und Klasse-II-Peptide aus soliden Nierenzell- und Cholangiozellulären Karzinomen

  2011cites this paper
• Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma.

  2011cites this paper
• تاثیر مایع رویی لنفوسیت T در القای بلوغ سلولهای دندریتیک (DC1) و تولید سلولهای موثر برای ایمونوتراپی تومور

  2011cites this paper
• Protivoopukholevye vaktsiny na osnove dendritom

  2010cites this paper
• Comparison of AAV/IL-7 autocrine (T cell) versus paracrine (DC) gene delivery for enhancing CTL stimulation and function

  2010cites this paper
• Dendritic/pancreatic carcinoma fusions for clinical use: Comparative functional analysis of healthy- versus patient-derived fusions.

  2010cites this paper
• Photodynamic Therapy of Tumors Can Lead to Development of Systemic Antigen-Specific Immune Response

  2010cites this paper
• Factors mediating successful oral vaccination with lipid-encapsulated Mycobacterium bovis BCG

  2010cites this paper
• Dendritic and tumor cell fusions transduced with adenovirus encoding CD40L eradicate B-cell lymphoma and induce a Th17-type response

  2010cites this paper
• Immunopathology and Infectious Diseases Heme Oxygenase-1 Expression in Murine Dendritic Cell Subpopulations Effect on CD 8 Dendritic Cell Differentiation in Vivo

  2010cites this paper
• Processing and cross-presentation of individual HLA-A, -B, or -C epitopes from NY-ESO-1 or an HLA-A epitope for Melan-A differ according to the mode of antigen delivery.

  2010cites this paper
• Protective anti‐tumour immune responses by murine dendritic cells pulsed with recombinant Tat‐carcinoembryonic antigen derived from Escherichia coli

  2009cites this paper
• An Autologous Therapeutic Dendritic Cell Vaccine Transfected with Total Lung Carcinoma RNA Stimulates Cytotoxic T Lymphocyte Responses Against Non-Small Cell Lung Cancer

  2009cites this paper
• The balance between immunity and tolerance: The role of Langerhans cells

  2009cites this paper
• Gene therapy strategies utilizing carcinoembryonic antigen as a tumor associated antigen for vaccination against solid malignancies

  2009cites this paper
• Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells.

  2009cites this paper
• In Vitro Activation of Cytotoxic T Lymphocytes By Muc1 PulsedDendritic Cells

  2009cites this paper
• Developing dendritic cell-based therapies to condition immune responses to novel oncogenic proteins and stem cells

  2009cites this paper
• Cyclophosphamide Unmasks an Antimetastatic Effect of Local Tumor Cryoablation

  2009cites this paper
• DC‐induced CD8+ T‐cell response is inhibited by MHC class II‐dependent DX5+CD4+ Treg

  2009cites this paper
• Fusion induced reversal of dendritic cell maturation: an altered expression of inflammatory chemokine and chemokine receptors in dendritomas.

  2009cites this paper
• Mechanisms of murine dendritic cell antitumor dysfunction in aging

  2009cites this paper
• Gene expression profile of tumor cell-fused or Noni ( Morinda citrifolia )-treated dendritic cells

  2009cites this paper
• Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties.

  2009cites this paper
• Detailed analysis for inducing specific CD8 T cells via a CpG-DNA adjuvant

  2009cites this paper
• In vitro activation of cytotoxic T-lymphocytes by hTERT-pulsed dendritic cells

  2009cites this paper
• Vaccine Targets in a Murine Model of Renal Cell Carcinoma.

  2009cites this paper
• Gene expression profile of tumor cell-fused or noni (Morinda citrifolia)-treated dendritic cells

  2009cites this paper
• Antigen mRNA-transfected, allogeneic fibroblasts loaded with NKT-cell ligand confer antitumor immunity.

  2009cites this paper
• RNA-based immunotherapy of cancer: role and therapeutic implications of dendritic cells - Retracted

  2009cites this paper
• Lymphangiogenesis and anti-tumor immune responses.

  2009cites this paper